1456 related articles for article (PubMed ID: 21493687)
1. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.
Cermak T; Doyle EL; Christian M; Wang L; Zhang Y; Schmidt C; Baller JA; Somia NV; Bogdanove AJ; Voytas DF
Nucleic Acids Res; 2011 Jul; 39(12):e82. PubMed ID: 21493687
[TBL] [Abstract][Full Text] [Related]
2. Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues.
Christian ML; Demorest ZL; Starker CG; Osborn MJ; Nyquist MD; Zhang Y; Carlson DF; Bradley P; Bogdanove AJ; Voytas DF
PLoS One; 2012; 7(9):e45383. PubMed ID: 23028976
[TBL] [Abstract][Full Text] [Related]
3. Targeting DNA double-strand breaks with TAL effector nucleases.
Christian M; Cermak T; Doyle EL; Schmidt C; Zhang F; Hummel A; Bogdanove AJ; Voytas DF
Genetics; 2010 Oct; 186(2):757-61. PubMed ID: 20660643
[TBL] [Abstract][Full Text] [Related]
4. TAL effector nuclease (TALEN) engineering.
Li T; Yang B
Methods Mol Biol; 2013; 978():63-72. PubMed ID: 23423889
[TBL] [Abstract][Full Text] [Related]
5. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction.
Doyle EL; Booher NJ; Standage DS; Voytas DF; Brendel VP; Vandyk JK; Bogdanove AJ
Nucleic Acids Res; 2012 Jul; 40(Web Server issue):W117-22. PubMed ID: 22693217
[TBL] [Abstract][Full Text] [Related]
6. Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes.
Li T; Huang S; Zhao X; Wright DA; Carpenter S; Spalding MH; Weeks DP; Yang B
Nucleic Acids Res; 2011 Aug; 39(14):6315-25. PubMed ID: 21459844
[TBL] [Abstract][Full Text] [Related]
7. Targeted mutagenesis of Arabidopsis thaliana using engineered TAL effector nucleases.
Christian M; Qi Y; Zhang Y; Voytas DF
G3 (Bethesda); 2013 Oct; 3(10):1697-705. PubMed ID: 23979944
[TBL] [Abstract][Full Text] [Related]
8. Assembly of Customized TAL Effectors Through Advanced ULtiMATE System.
Yang J; Guo S; Yuan P; Wei W
Methods Mol Biol; 2016; 1338():49-60. PubMed ID: 26443213
[TBL] [Abstract][Full Text] [Related]
9. Efficient TALEN construction and evaluation methods for human cell and animal applications.
Sakuma T; Hosoi S; Woltjen K; Suzuki K; Kashiwagi K; Wada H; Ochiai H; Miyamoto T; Kawai N; Sasakura Y; Matsuura S; Okada Y; Kawahara A; Hayashi S; Yamamoto T
Genes Cells; 2013 Apr; 18(4):315-26. PubMed ID: 23388034
[TBL] [Abstract][Full Text] [Related]
10. TAL effector specificity for base 0 of the DNA target is altered in a complex, effector- and assay-dependent manner by substitutions for the tryptophan in cryptic repeat -1.
Doyle EL; Hummel AW; Demorest ZL; Starker CG; Voytas DF; Bradley P; Bogdanove AJ
PLoS One; 2013; 8(12):e82120. PubMed ID: 24312634
[TBL] [Abstract][Full Text] [Related]
11. TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain.
Li T; Huang S; Jiang WZ; Wright D; Spalding MH; Weeks DP; Yang B
Nucleic Acids Res; 2011 Jan; 39(1):359-72. PubMed ID: 20699274
[TBL] [Abstract][Full Text] [Related]
12. E-TALEN: a web tool to design TALENs for genome engineering.
Heigwer F; Kerr G; Walther N; Glaeser K; Pelz O; Breinig M; Boutros M
Nucleic Acids Res; 2013 Nov; 41(20):e190. PubMed ID: 24003033
[TBL] [Abstract][Full Text] [Related]
13. TAL effectors: tools for DNA targeting.
Jankele R; Svoboda P
Brief Funct Genomics; 2014 Sep; 13(5):409-19. PubMed ID: 24907364
[TBL] [Abstract][Full Text] [Related]
14. Programmable DNA-binding proteins from Burkholderia provide a fresh perspective on the TALE-like repeat domain.
de Lange O; Wolf C; Dietze J; Elsaesser J; Morbitzer R; Lahaye T
Nucleic Acids Res; 2014 Jun; 42(11):7436-49. PubMed ID: 24792163
[TBL] [Abstract][Full Text] [Related]
15. Exploring the transcription activator-like effectors scaffold versatility to expand the toolbox of designer nucleases.
Juillerat A; Beurdeley M; Valton J; Thomas S; Dubois G; Zaslavskiy M; Mikolajczak J; Bietz F; Silva GH; Duclert A; Daboussi F; Duchateau P
BMC Mol Biol; 2014 Jul; 15():13. PubMed ID: 24997498
[TBL] [Abstract][Full Text] [Related]
16. Designer TAL effectors induce disease susceptibility and resistance to Xanthomonas oryzae pv. oryzae in rice.
Li T; Huang S; Zhou J; Yang B
Mol Plant; 2013 May; 6(3):781-9. PubMed ID: 23430045
[TBL] [Abstract][Full Text] [Related]
17. Mojo Hand, a TALEN design tool for genome editing applications.
Neff KL; Argue DP; Ma AC; Lee HB; Clark KJ; Ekker SC
BMC Bioinformatics; 2013 Jan; 14():1. PubMed ID: 23323762
[TBL] [Abstract][Full Text] [Related]
18. Breaking the code of DNA binding specificity of TAL-type III effectors.
Boch J; Scholze H; Schornack S; Landgraf A; Hahn S; Kay S; Lahaye T; Nickstadt A; Bonas U
Science; 2009 Dec; 326(5959):1509-12. PubMed ID: 19933107
[TBL] [Abstract][Full Text] [Related]
19. Activities and specificities of homodimeric TALENs in Saccharomyces cerevisiae.
Aouida M; Piatek MJ; Bangarusamy DK; Mahfouz MM
Curr Genet; 2014 May; 60(2):61-74. PubMed ID: 24081604
[TBL] [Abstract][Full Text] [Related]
20. Rapid and highly efficient construction of TALE-based transcriptional regulators and nucleases for genome modification.
Li L; Piatek MJ; Atef A; Piatek A; Wibowo A; Fang X; Sabir JS; Zhu JK; Mahfouz MM
Plant Mol Biol; 2012 Mar; 78(4-5):407-16. PubMed ID: 22271303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
